drug targets

20 September 2022

New study presents hope for patients with chemo-resistant breast cancer

Bioinformatics study identifies new SNPs never before seen in cancer

Single-cell RNA sequencing suggests new treatment options for diabetic kidney disease

Overcoming enzalutamide drug resistance in prostate cancer

GPC1 – a new target for colorectal cancer treatment

An LRRK2 inhibitor shows promise as a Parkinson’s disease therapy

Immune cell features correlate with survival in COVID-19 patients